Methodology

All entries for: Zhaoke Ophthalmology

July 24, 2025

Zhaoke Ophthalmology

Orphan Drug Designation

FDA orphan drug designation: treatment of retinoblastoma

Disease Area: Rare Diseases
Source
Scroll to Top